Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pruijm

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Revue Medicale Suisse|October 8, 2009
[Hypertension genetics: what have we learned so far?]M Pruijm, M Bochud, M Burnier
Revue Medicale Suisse|April 2, 2013
[Dialysis and ecology: can we do better in the future?]Y Vuignier, M Pruijm, F Jarrayah, et al.
Revue Medicale Suisse|February 8, 2011
[Managing hypertension: the uncertainty of definitions and targets]V Forni, G Wuerzner, M Pruijm, et al.
Revue Medicale Suisse|October 8, 2009
[Hypertension in solid organ transplants]N Glatz, G Wuerzner, M Pruijm, et al.
Revue Medicale Suisse|April 23, 2015
[Renal aspects of sodium glucose cotransporter 2 inhibitors]F Beaud, M Pruijm, A Humbert, et al.
Revue Medicale Suisse|September 30, 2011
[Renal sympathetic denervation: perspective of a promising treatment for hypertension]M Cassat, G Wuerzner, M Pruijm, et al.
Revue Medicale Suisse|April 23, 2015
[What to expect from dialysis in the future?]M Schneider, S Kissling, F Saucy, et al.
Revue Medicale Suisse|March 29, 2012
[Sleep disorders in patients with chronic renal insufficiency]M-E Muller, R Heinzer, M Pruijm, et al.
Clinical Nephrology|September 19, 2009
Improvement in secondary hyperparathyroidism due to drug adherence monitoring in dialysis patientsM Pruijm, D Teta, G Halabi, et al.
Revue Medicale Suisse|September 30, 2011
[Do endothelin receptors antagonists have a place in the treatment of arterial hypertension?]V Forni, G Wuerzner, M Pruijm, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Revue Medicale Suisse|October 8, 2009
[Hypertension genetics: what have we learned so far?]M Pruijm, M Bochud, M Burnier
Revue Medicale Suisse|April 2, 2013
[Dialysis and ecology: can we do better in the future?]Y Vuignier, M Pruijm, F Jarrayah, et al.
Revue Medicale Suisse|February 8, 2011
[Managing hypertension: the uncertainty of definitions and targets]V Forni, G Wuerzner, M Pruijm, et al.
Revue Medicale Suisse|October 8, 2009
[Hypertension in solid organ transplants]N Glatz, G Wuerzner, M Pruijm, et al.
Revue Medicale Suisse|April 23, 2015
[Renal aspects of sodium glucose cotransporter 2 inhibitors]F Beaud, M Pruijm, A Humbert, et al.
Revue Medicale Suisse|September 30, 2011
[Renal sympathetic denervation: perspective of a promising treatment for hypertension]M Cassat, G Wuerzner, M Pruijm, et al.
Revue Medicale Suisse|April 23, 2015
[What to expect from dialysis in the future?]M Schneider, S Kissling, F Saucy, et al.
Revue Medicale Suisse|March 29, 2012
[Sleep disorders in patients with chronic renal insufficiency]M-E Muller, R Heinzer, M Pruijm, et al.
Clinical Nephrology|September 19, 2009
Improvement in secondary hyperparathyroidism due to drug adherence monitoring in dialysis patientsM Pruijm, D Teta, G Halabi, et al.
Revue Medicale Suisse|September 30, 2011
[Do endothelin receptors antagonists have a place in the treatment of arterial hypertension?]V Forni, G Wuerzner, M Pruijm, et al.
Pageof 2